DNA macrorestriction profiles and antifungal susceptibility of Candida (Torulopsis) glabrata

被引:12
|
作者
Cormican, MG [1 ]
Hollis, RJ [1 ]
Pfaller, MA [1 ]
机构
[1] UNIV IOWA,COLL MED,DEPT PATHOL,DEPT MED MICROBIOL,IOWA CITY,IA 52242
关键词
D O I
10.1016/S0732-8893(96)00083-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Candida (Torulopsis) glabrata is an emerging nosocomial pathogen that may be relatively resistant to fluconazole. A series of 75 isolates (blood, urine, tissue, and other sites) from 16 patients (1 to 12 isolates per patient) at a single university medical center were analyzed by pulsed field gel electrophoresis (PFGE) of restriction endonuclease digests of chromosomal DNA. The MICs of the isolates for amphotericin B, flucytosine, fluconazole, and itraconazole, were determined by a microdilution broth method. A preliminary study of seven restriction enzymes, three producing small fragments (Hinf I, Hind III, Eco XI) and four producing large fragments (fag I, BssH II, Sfi I, Not I) identified Not I as giving interpretable banding patterns. Isolates were considered of different types if they differed by two or move bands. Sixteen distinct DNA types (A to P) were identified. Karyotyping was used an additional technique to compare strains with a common PFGE type. Most patients were colonized or infected with a single type at multiple body sites and over time. One PFGE type was shared by four patients housed in different areas of the institution at different times. For two of these four patients, the karyotype was also indistintuishable. Five patients were each colonized with two distinct types. The MIC of the strains studied were amphotericin B 0.5-1.0 mu g/ml (MIC(90) = 1.0 mu g/ ml), 5-fluorocytosine 0.25 --> 256 mu g/ml (MIC(90) = 2 mu g/ml), fluconazole 0.25 --> 128 mu g/ml (MIC(90) = 32 mu g/ml), and itraconazole 0.06-8.0 mu g/ml (MIC(90) = 2.0 mu g/ml). Molecular typing by PFGE using Not I digestion is It useful technique for epidemiological investigation as epidemiologically related isolates are generally identical and epidemiologically unrelated isolates are different by this method.
引用
收藏
页码:83 / 87
页数:5
相关论文
共 50 条
  • [21] JANUS GREEN SENSITIVITY AS A CRITERION FOR DIFFERENTIATION OF CANDIDA-PARAPSILOSIS, TORULOPSIS-GLABRATA AND TORULOPSIS-CANDIDA
    SOBCZAK, H
    MYKOSEN, 1981, 24 (12): : 731 - 742
  • [22] Genetic Analysis of Candida glabrata from Candiduric Patients Using Microsatellite Length Polymorphism, Antifungal Susceptibility, and Enzymatic Profiles
    Gharaghani, Maral
    Rezaei-Matehkolaei, Ali
    Hardani, Amir Kamal
    Mahmoudabadi, Ali Zarei
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2021, 14 (01)
  • [23] Unexpected effects of the monoamine oxidase A inhibitor clorgyline on antifungal susceptibility of Candida glabrata
    Nagayoshi, Y.
    Miyazaki, T.
    Minematsu, A.
    Hosogaya, N.
    Morinaga, Y.
    Nakamura, S.
    Imamura, Y.
    Izumikawa, K.
    Kakeya, H.
    Yanagihara, K.
    Tashiro, T.
    Kohno, S.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S119 - S120
  • [24] Roles of Calcineurin and Crz1 in Antifungal Susceptibility and Virulence of Candida glabrata
    Miyazaki, Taiga
    Yamauchi, Shunsuke
    Inamine, Tatsuo
    Nagayoshi, Yosuke
    Saijo, Tomomi
    Izumikawa, Koichi
    Seki, Masafumi
    Kakeya, Hiroshi
    Yamamoto, Yoshihiro
    Yanagihara, Katsunori
    Miyazaki, Yoshitsugu
    Kohno, Shigeru
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (04) : 1639 - 1643
  • [25] Isolation and characterization of a species-specific DNA fragment for identification of Candida (Torulopsis) glabrata by PCR
    Becker, K
    Badehorn, D
    Keller, B
    Schulte, M
    Böhm, KH
    Peters, G
    Fegeler, W
    JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (09) : 3356 - 3359
  • [26] 5-FLUOROCYTOSINE RESISTANCE IN CANDIDA SPP AND TORULOPSIS GLABRATA
    SCHONEBECK, J
    ANSEHN, S
    SABOURAUDIA-JOURNAL OF MEDICAL AND VETERINARY MYCOLOGY, 1973, 11 (MAR): : 10 - 20
  • [27] Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species
    Nagayoshi, Yohsuke
    Miyazaki, Taiga
    Shimamura, Shintaro
    Nakayama, Hironobu
    Minematsu, Asuka
    Yamauchi, Shunsuke
    Takazono, Takahiro
    Nakamura, Shigeki
    Yanagihara, Katsunori
    Kohno, Shigeru
    Mukae, Hiroshi
    Izumikawa, Koichi
    PLOS ONE, 2017, 12 (07):
  • [28] Late complications of Candida (Torulopsis) glabrata fungemia: Description of a phenomenon
    Gumbo, T
    Chemaly, RF
    Isada, CM
    Hall, GS
    Gordon, SM
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2002, 34 (11) : 817 - 818
  • [29] Constructive pericarditis caused by Candida (Torulopsis) glabrata in an immunocompetent patient
    Neughebauer, BI
    Alvarez, VE
    Harb, TS
    Keeper, M
    CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) : 249 - 249
  • [30] ANTIFUNGAL ACTIVITY OF A NEW TRIAZOLE, D0870, COMPARED WITH 4 OTHER ANTIFUNGAL AGENTS TESTED AGAINST CLINICAL ISOLATES OF CANDIDA-GLABRATA AND TORULOPSIS-GLABRATA
    PFALLER, MA
    BALE, MJ
    BUSCHELMAN, B
    RHOMBERG, P
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1994, 19 (02) : 75 - 80